ZAMBROWICZ BRIAN P 4
4 · LEXICON PHARMACEUTICALS, INC./DE · Filed Feb 4, 2013
Insider Transaction Report
Form 4
ZAMBROWICZ BRIAN P
EVP, Chief Scientific Officer
Transactions
- Exercise/Conversion
Common Stock
2013-01-31+42,100→ 216,580 total - Tax Payment
Common Stock
2013-01-31$2.11/sh−13,499$28,483→ 203,081 total - Exercise/Conversion
Restricted Stock Units (Phantom Stock)
2013-01-31−42,100→ 0 total→ Common Stock (42,100 underlying)
Footnotes (3)
- [F1]Each restricted stock unit represents a contingent right to receive one share of common stock.
- [F2]Withholding of a portion of issued shares by the Company in satisfaction of shareholder's tax withholding obligations with respect thereto.
- [F3]Restricted stock units vest with respect to 100% of the shares subject to the restricted stock unit upon the dosing of the first patient in a pivotal human clinical trial in any country, the results of which could be used to establish safety and efficacy of a pharmaceutical product discovered or developed by the Company (whether or not licensed by the Company to a third party) as a basis for a New Drug Application with the U.S. Food and Drug Administration or that would otherwise satisfy the requirements of 21 CFR 321.21(c) or its foreign equivalent.